“METASTATIC CHOLANGIOCARCINOMA AS A TARGET OF MOLECULAR-DIRECTED THERAPY”, Вопр. онкол., vol. 64, no. 5, pp. 671–677, May 2018, doi: 10.37469/0507-3758-2018-64-5-671-677.